systemic immunomodulating therapies

Coronavirus & Atopic Dermatitis Reporting Registry
101801018010180SECURE-ADEPI Health has graciously supported the COVID-19 News and Resource Center. SECURE-AD (Surveillance Epidemiology of Corona Virus (COVID-19) Under Research Exclusion - Atopic Dermatitis) is a secure, online, de-identified international reporting registry for health care providers to report outcomes of COVID-19 in atopic dermatitis (AD) patients. Clinicians worldwide are encouraged to report al …
SECURE-AD